GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Total Current Liabilities (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Total Current Liabilities came in at $14.1 million in Q2 2026, down 52.33% on a YoY basis from $29.7 million in Q2 2025, and down 6.69% quarter-over-quarter from $15.2 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Total Current Liabilities (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Total Current Liabilities for 12 consecutive years, with $14.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities fell 52.33% year-over-year to $14.1 million; the trailing twelve-month figure through Jun 2026 stood at $14.1 million (down 52.33% YoY), and the FY2025 full-year result was $15.2 million, down 44.97% from the prior year.
  • Total Current Liabilities declined to $14.1 million in Q2 2026 per GRDX's latest filing, from $15.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $33.5 million in Q3 2025 and bottomed at $2.5 million in Q3 2023.
  • Historically, Total Current Liabilities has averaged $14.0 million across 5 years, with a median of $14.2 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Total Current Liabilities tumbled 81.54% in 2023, then soared 779.14% in 2024.
  • Over 5 years, Total Current Liabilities stood at $2.5 million in 2022, then climbed by 26.17% to $3.1 million in 2023, then surged by 779.14% to $27.5 million in 2024, then plunged by 44.97% to $15.2 million in 2025, then retreated by 6.69% to $14.1 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $14.1 million, $15.2 million, and $33.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 14.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.15 Mn
Dec 31, 2025 15.16 Mn
Sep 30, 2025 33.52 Mn
Jun 30, 2025 29.68 Mn
Mar 31, 2025 28.74 Mn
Dec 31, 2024 27.55 Mn
Sep 30, 2024 15.69 Mn
Jun 30, 2024 15.38 Mn
Mar 31, 2024 6.17 Mn
Dec 31, 2023 3.13 Mn
Sep 30, 2023 2.48 Mn
Jun 30, 2023 3.26 Mn
Mar 31, 2023 2.62 Mn
Dec 31, 2022 2.48 Mn
Sep 30, 2022 6.69 Mn
Jun 30, 2022 17.28 Mn
Mar 31, 2022 14.22 Mn
Dec 31, 2021 12.30 Mn
Sep 30, 2021 19.10 Mn
Jun 30, 2021 6.45 Mn